Multiple Keratoacanthomas, Philadelphia Chromosome+ Acute Lymphoblastic Leukemia, and Dasatinib: A Case Report

Multiple Keratoacanthomas, Philadelphia Chromosome+ Acute Lymphoblastic Leukemia, and Dasatinib: A Case Report

Background: Treatment for adult Philadelphia chromosome+ acute lymphoblastic leukemia includes using dasatinib, a tyrosine kinase inhibitor. Cutaneous squamous cell carcinomas and keratoacanthomas are common findings in patients treated with BRAF inhibitors of tyrosine kinases. No documentation of d...

Full description

Bibliographic Details
Main Authors: Siddhant Thukral, Lloyd E. King Jr, David H. Horowitz
Format: Article
Language:English
Published: University Library System, University of Pittsburgh 2015-11-01
Series:International Journal of Medical Students
Subjects:
dasatinib; keratoacanthoma
carcinoma,
squamous cell
lymphoblastic leukemia
acute; bcr-abl tyrosine kinase
Online Access:http://ijms.info/IJMS/article/view/137

Internet

http://ijms.info/IJMS/article/view/137

Similar Items